Rewriting the Blueprint: How CRISPR and AI Free Us from Inherited Destiny

Trevor Martin, CEO of Mammoth Biosciences, joins us to discuss how biology, AI, and engineering are converging to create a biotechnology operating system — a platform of reusable components that can be rapidly deployed to tackle new conditions. We explore the groundbreaking story of baby K.J., the first newborn to receive a personalized CRISPR therapy for a rare disease, and look ahead to a future where genome editing moves beyond rare disorders to common diseases like heart disease. At its core, this vision points to a profound shift: a world where humanity is no longer bound by inherited genetics, but empowered to lead healthy lives that were once unimaginable.